SWOG clinical trial number
SWOG-8400/05

Evaluation of AT-125 and Fludarabine Phosphate in Central Nervous System Tumors

Closed
Phase
Published
Abbreviated Title
Evaluation of AT-125 and Fludarabine Phosphate in Central Nervous System Tumors
Activated
12/07/1984
Closed
01/15/1987

Publication Information Expand/Collapse

1991

Phase II evaluation of fludarabine phosphate in patients with central nervous system tumors: A Southwest Oncology Group study.

SA Taylor;J Crowley;FS Vogel;JJ Townsend;HJ Eyre;KA Jaeckle;HE Hynes;JT Guy IND 9:195-197

Objective antitumor activity of acivicin in patients with recurrent CNS malignancies: A Southwest Oncology Group study.

SA Taylor;J Crowley;JT Guy;HJ Eyre;KA Jaeckle;HE Hynes;RL Stephens JCO 9:1476-1479

1987

Randomized phase II trials of acivicin (AT-125 NSC 163501) andfludarabine (2-fluoro-ara-AMP, NSC 312887) (2 FLAMP) in recurrentmalignant gliomas.

S Taylor;HJ Eyre ASCO 6:71 (#275)